Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 35, 2024 - Issue 1
Submit an article Journal homepage
435
Views
0
CrossRef citations to date
0
Altmetric
Case Report

A case of generalized eosinophilic pustular folliculitis: treatment with JAK inhibitor

Chunzhi Zhenga Hospital for Skin Diseases, Shandong First Medical University, Jinan, Shandong, China;b Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences, Jinan, Shandong, ChinaView further author information
,
Yueqian Yua Hospital for Skin Diseases, Shandong First Medical University, Jinan, Shandong, China;b Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences, Jinan, Shandong, ChinaView further author information
,
Guizhi Zhoua Hospital for Skin Diseases, Shandong First Medical University, Jinan, Shandong, China;b Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences, Jinan, Shandong, ChinaView further author information
&
Hong Liua Hospital for Skin Diseases, Shandong First Medical University, Jinan, Shandong, China;b Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences, Jinan, Shandong, ChinaCorrespondence[email protected]
View further author information
Article: 2331785 | Received 02 Jan 2024, Accepted 27 Feb 2024, Published online: 26 Mar 2024

References

  • Nomura T, Katoh M, Yamamoto Y, et al. Eosinophilic pustular folliculitis: a proposal of diagnostic and therapeutic algorithms. J Dermatol. 2016;43(11):1–4. doi:10.1111/1346-8138.13359.
  • Ishiguro N, Shishido E, Okamoto R, et al. Ofuji’s disease: a report on 20 patients with clinical and histopathologic analysis. J Am Acad Dermatol. 2002;46(6):827–833. doi:10.1067/mjd.2002.120533.
  • Lee WJ, Won KH, Won CH, et al. Facial and extrafacial eosinophilic pustular folliculitis: a clinical and histopathological comparative study. Br J Dermatol. 2014;170(5):1173–1176. doi:10.1111/bjd.12755.
  • Peckruhn M, Elsner P, Tittelbach J. Eosinophilic dermatoses. J Dtsch Dermatol Ges. 2019;17(10):1039–1051. doi:10.1111/ddg.13943.
  • King B, Lee AI, Choi J. Treatment of hypereosinophilic syndrome with cutaneous involvement with the JAK inhibitors tofacitinib and ruxolitinib. J Invest Dermatol. 2017;137(4):951–954. doi:10.1016/j.jid.2016.10.044.
  • Yamane T, Hashiramoto A. A case of chronic eosinophilic pneumonia associated with rheumatoid arthritis in glucocorticoid-free remission with JAK inhibitor: a case report. Medicine. 2023;102(13):e33396. doi:10.1097/MD.0000000000033396.
  • Chastagner M, Shourik J, Jachiet M, et al. Treatment of eosinophilic annular erythema: retrospective multicenter study and literature review. Ann Dermatol Venereol. 2022;149(2):123–127. doi:10.1016/j.annder.2021.07.007.
  • Martinez J, Manjaly C, Manjaly P, et al. Janus kinase inhibitors and adverse events of acne: a systematic review and meta-analysis. JAMA Dermatol. 2023;159(12):1339–1345. doi:10.1001/jamadermatol.2023.3830.
  • Sun C, Su Z, Zeng Y-P. Association of risk of incident acne and treatment with systemic Janus kinase inhibitors in atopic dermatitis: a systematic review and meta-analysis. Inflamm Res. 2023;72(9):1861–1871. doi:10.1007/s00011-023-01789-x.
  • Leiferman KM, Peters MS. Eosinophil-related disease and the skin. J Allergy Clin Immunol Pract. 2018;6(5):1462.e6–1482.e6. doi:10.1016/j.jaip.2018.06.002.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.